- Research article
- Open Access
The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforin
© Ibana et al.; licensee BioMed Central Ltd. 2012
- Received: 11 July 2012
- Accepted: 3 December 2012
- Published: 7 December 2012
The local tissue microenvironment plays an important role in the induction, homing, maintenance and development of effector functions of T cells. Thus, site-specific differences in phenotypes of mucosal and systemic T cell populations have been observed. Chlamydia trachomatis most commonly infects the endocervix in women, yet little is known about Chlamydia-specific effector T cell immunity at this unique mucosal site. Our previous flow-cytometry-based study of cervical-cytobrush retrieved cells indicated that CD8 T cells are significantly increased in the C. trachomatis-infected human endocervix. The cytolytic function of CD8 T cells is important in the protective immunity against many intracellular pathogens, and requires the cytolytic granule perforin to facilitate the entry of other molecules that mediate the lysis of target cells. Determination of perforin expression of the CD8 T cell population in the endocervix would therefore provide insights on the granule-mediated cytolytic potential of these cells at this site.
Our histological data revealed that C. trachomatis-infected tissues have significantly higher numbers of CD3 and CD8 T cells compared to non-infected tissues (p<0.01), and that the majority of CD8+ cells do not express perforin in situ. A subsequent flow cytometric analysis of paired blood and endocervix-derived cells (n=16) revealed that while all the CD8 T cell subsets: naïve, effector memory (TEM), central memory (TCM) and terminally differentiated effector memory (TEMRA) can be found in the blood, the endocervix is populated mainly by the TEM CD8 T cell subset. Our data also showed that perforin expression in the TEM population is significantly lower in the endocervix than in the blood of C. trachomatis positive women (n=15; p<0.0001), as well as in C. trachomatis-negative individuals (n=6; p<0.05). Interestingly, our in vitro co-culture study suggests that the exposure of HeLa 229 cervical epithelial cells to IFN gamma could potentially induce a decrease in perforin content in CD8 TEM cells in the same microenvironment.
The low perforin content of CD8 TEM cells in the endocervix, the local site of C. trachomatis infection in women, may reflect the unique immunological environment that balances immune protection against sexually transmitted infections and immune- tolerance to support conception.
- Bacterial Vaginosis
- Nucleic Acid Amplification Test
- Cervical Epithelial Cell
- Perforin Expression
- Endocervical Cell
CD8 T cells are key cellular components in the control of many intracellular microbial infections via their cytolytic function. Chlamydia trachomatis serovars D-K are intracellular bacteria that infect the columnar epithelial cells of the genital tract. Epithelial cells can present antigens in the context of MHC class I and activate a CD8 T cell immune response. Thus, investigation of the CD8 T cell cytolytic response to C. trachomatis infection is important as it could reveal a mechanism by which the bacterium is deprived of its intracellular niche. The major CD8 T cell cytolytic pathway involves the perforin and granzyme mediated induction of apoptosis [1, 2]. Perforin mediates the delivery of granzymes to target cells by homopolymerization in the plasma membrane in a Ca2+ dependent manner producing pores that acts as a channel for granzyme entry [3, 4]. Perforin is suggested to be necessary in CD8 T cell cytolytic activity, as perforin deficient mice have reduced efficiency in controlling viral infection .
During the course of infection, CD8 T cells differentiate and this is accompanied by changes in the expression of surface markers and functional capacity . Naïve T cells are activated when they encounter their specific peptide-MHC complexes on professional antigen presenting cells . A memory T cell differentiation pathway has been established by the group of Sallusto and Lanzavecchia, and others, whereby subsequent to antigen encounter, T cells proliferate and undergo phenotypic changes that modify their tissue homing properties [8–10]. Antigen-specific cells possessing a naïve-like phenotype (CD45RA+ CCR7+) are recruited into a pre-memory subset before reaching the central memory (TCM) and effector memory (TEM) stages that are characterized as CD45RA-CCR7+ and CD45RA-CCR7- respectively. Eventually, these memory T cells reach a terminally differentiated effector stage (TEMRA) characterized as CD45RA+ CCR7-. Progression of a T cell through these subsets is associated with the acquisition of effector function and loss of proliferative potential [ibid]. Effector CD8 T cells acquire the capacity to migrate to extra lymphoid sites to sites of infection, and deliver perforin and granzyme at the immunological synapse to kill infected target cells . CD8 T cell differentiation in response to infection is thus characterized by the acquisition of immunological properties that allow them to successfully clear intracellular pathogens.
Evidence that specific tissue microenvironments significantly influence CD8 T cell phenotype and function is accumulating. For example, Masopust et al., illustrated that the gastrointestinal microenvironment promotes differentiation of a unique memory CD8 T cell population, and that CD8 T cells can switch phenotypes with changes in anatomic location . The influence of the anatomic micromilieu was also illustrated by a study by Shacklett et al., who demonstrated that unlike those in peripheral blood, CD8 T cells resident in the gastrointestinal tract of normal macaques were low in perforin. The absence of perforin in normal GI tissue was interpreted to be a mechanism by which the anatomical integrity of this mucosal site is protected, though it provides advantages for pathogens .
The female genital tract (FGT), like the GI tract, is also frequently exposed to foreign antigens, including commensal and pathogenic microorganisms. Furthermore, as a reproductive site, the FGT must tolerate foreign antigens to support conception. We thus hypothesized that CD8 T cells in the endocervix may also have limited cytolytic potential compared to their peripheral counterparts. Therefore, to investigate the phenotype of CD8 T cells in the FGT in the absence and presence of C. trachomatis infection, we sampled endocervical CD8 T cells from women to characterize the immune cell population, and assess the cytolytic potential of CD8 T cells at this site. In addition, using an in vitro approach, we further tested whether the presence of IFN gamma in a microenvironment could influence the perforin expression of CD8 TEM cells.
CD8 T cells infiltrate the human endocervix during C. trachomatis infection
The CD8 T cell repertoire in the human endocervix is distinct from the periphery
Effector memory CD8 T cells (TEMs) in the human endocervix have limited perforin expression
IFN gamma exposure of epithelial cells could potentially mediate the downmodulation of perforin expression of TEM CD8 T cells in the cervical microenvironment
We found that the level of perforin expression by the control CD8 TEM cells from PBLs cultured in the absence of HeLa 229 cells did not shift in the presence of IFN gamma (Figure 7C – left panel). However, when we co-cultured PBLs with HeLa cells, the addition of IFN gamma in the culture medium resulted in the negative shift in the fluorescence intensity of perforin, suggesting a downmodulation of the expression of this protein (Figure 7C – right panel). Therefore, our in vitro data suggest that IFN gamma could be potential mediator of the downmodulation of perforin expression in CD8 TEM cells.
Using both in situ tissue-based and ex vivo cytobrush-sampling protocols we confirm here that CD8 T cells comprise a significant component of the endocervical T cell infiltrate during C. trachomatis infection. Moreover, we also report that endocervical CD8 T cells are primarily of the TEM subtype, but, unlike their peripheral counterparts that express high levels of perforin, these cells have low levels of this protein. Since low perforin content is observed in CD8 TEM cells from both normal and C. trachomatis-infected tissues we hypothesize that the endocervical milieu drives this phenotype. That the endocervical CD8 TEM subpopulation is low in perforin may reflect an immunological response pattern that supports feto-maternal tolerance and facilitates a fine balance between protection of tissue integrity and defence against sexually transmitted pathogens.
Human studies and animal models of C. trachomatis infection have previously demonstrated recruitment of immune cells to the local site of infection. [18, 22–29]. Compelling evidence for the ability of Chlamydia-specific CD8 T cells to migrate to infected murine FGT has been presented by Roan and Starnbach who generated retrogenic mice expressing a T cell receptor specific for CrpA, a Chlamydia specific T cell antigen . They observed that adoptively-transferred Chlamydia- specific retrogenic CD8 T cells proliferated in genital tract-draining lymph nodes of naïve recipients in response to genital C. trachomatis challenge. Further, they also demonstrated that the adoptively transferred Chlamydia-specific CD8 T cells successfully migrated to the genital mucosa and acquired the ability to produce IFN gamma [ibid]. In our earlier study, in which we observed elevated endocervical T cell numbers during culture positive endocervical C. trachomatis infections, we also noted that T cells numbers significantly decline in these women post successful antibiotic treatment . We interpret these observations to suggest that active C. trachomatis infection is most likely responsible for the recruitment of T cells at the site of infection. We also observed that CD8 T cells constitute a significant proportion of the T cell infiltrates found in the endocervix [ibid]. Thus, our data from human study, and reports based on animal studies mutually support the finding that CD8 T cells migrate into the FGT in response to C. trachomatis infection.
Intriguingly, although animal and human studies suggest that CD8 T cells are recruited to the site of C. trachomatis infection, the role of their cytolytic activity in protective immunity remains uncertain. Some studies suggest that CD8 T cells can play a role in clearance of C. trachomatis infection [26, 31], while other studies implicate these cells to be responsible for immune-mediated pathology. As an example, Voorhis et al. found an association between perforin positive CD8 T cells and salpingeal tissue scarring in non-human primate model of C. trachomatis infection . Further, in a study by Murthy et al., CD8 T cells were suggested to mediate oviduct pathology (hydrosalpinx) following C. muridarum infection in mice, but this was via their TNFα activity. This finding was demonstrated by the restoration of hydrosalpinx upon repletion of mice genetically deficient in CD8 T cells with perforin-deficient, but not with TNFα-deficient, CD8 T cells . Therefore, currently, there is no direct evidence that perforin plays a role in immune-mediated pathology by CD8 T cells during C. trachomatis infection. Furthermore, evidence based on lung and genital infection studies in perforin-knockout mice suggests that perforin is not required for clearance of murine chlamydial infection . Based on these animal models, we could surmise that the perforin-dependent CD8 T cell cytolytic response may not play a critical role in controlling C. trachomatis burden in the human endocervix.
While studies by others and us suggest a limited role for perforin-dependent CD8 T cell cytolytic activity against C. trachomatis, we do not discount the possibility that CD8 T cells may be involved in perforin-independent immune mechanisms. Particularly, we believe that during C. trachomatis infection in the human endocervix, CD8 T cells may significantly contribute to the accumulation of IFN gamma at this site as demonstrated in murine studies by Starnbach’s group [18, 31]. This finding is supported by a report based on a human study that IFN gamma levels are elevated in the endocervix of C. trachomatis-infected women compared to uninfected controls .
Two of the possible mechanisms that could induce low perforin content in CD8 TEM in Chlamydia-infected endocervix are discussed here. These are: 1) CD8 TEM cells that have migrated to the endocervix in response to C. trachomatis infection exhibit active and continuous degranulation resulting in the loss of their perforin content, and; 2) The physiologic pressure in the female genital tract drives perforin downmodulation in CD8 TEM cells. To our knowledge, the differences in degranulation sensitivity and the rates of granule protein recovery between CD8 T cells and NK cells are not yet well defined. However, we note here that unlike the CD8 TEM cells, we observed that endocervical NK cells have a high perforin content (representative data shown in Figure 4), suggesting that our observations are not due to spontaneous and continuous degranulation of all cytolytic immune cells. Further, although not the focus of this study, we believe that our data suggests that NK cells could maintain a high cytolytic potential in the endocervix, and are likely to be a key immune cell population that mediates host cytolytic immune response to C. trachomatis infection. Consistent to this notion is our previous finding that the NK cell ligand expression in C. trachomatis infected endocervical epithelial cells renders these cells more susceptible to NK cell-mediated cytolysis .
To address the first possibility, a study on degranulation status of CD8 T cell infiltrates in the endocervix would need to be undertaken. One experimental approach to test this possibility would be the concurrent measurement of the surface expression of CD107a, a marker of degranulation , and the intracellular perforin content of CD8 T cells derived from the endocervix. In principle, the low perforin content of CD8 T cells in the endocervix of women could result from their degranulation in response to stimulation of resident Chlamydia-specific, and other pathogen – specific CD8 T cells at this site. As we have not tested for degranulation in this study, we do not discount that this is a plausible mechanism that could underlie the low perforin content of CD8 T cells in the endocervix. Therefore, further study needs to be undertaken to test this possibility.
The second possibility, that physiological pressure in the endocervix drives the low perforin content of CD8 T cells, was explored in this study. Specifically, we have provided a proof-of-principle that the IFN gamma exposure of cervical epithelial cells could potentially downmodulate perforin expression of CD8 TEM cells in the same microenvironment. IFN gamma has been well established to induce indoleamine-2,3-dioxygenase (IDO) expression in epithelial cells. We also confirmed this in the HeLa 229 cells that were utilized in our in vitro study by immunoblotting HeLa 229 lysates with an IDO1-specific antibody (data not shown). IDO has been reported to impair the cytotoxic function of CD8 T cells by reducing perforin expression in these cells . Therefore, IFN gamma secretion by infiltrating CD8 T cells during C. trachomatis infection may lead to an increase in the levels of IDO in the endocervix that could induce the decrease in perforin content of the local CD8 TEM cells. While we have not yet been able to test this hypothesis in vivo, we believe that further investigation into IDO and perforin regulation in the endocervix during C. trachomatis infection is warranted to determine the mechanisms and functional significance of the low perforin content of CD8 TEM cells in this unique anatomical region.
Interestingly, there are indications that our hypothesis, proposing that IFN gamma and IDO could mediate the downmodulation perforin expression of endocervical CD8 T cells during C. trachomatis infection, could be generally operant in the FGT even in the absence of chlamydial infection. The first series of studies that support our hypothesis includes the observation that endometrial tissues have high levels of IFN gamma at the secretory stage of the menstrual cycle but not during the proliferative phase . Consistent with these findings are immunohistochemical and mRNA-based analyses demonstrating that IDO expression is low during the proliferative stage, but is elevated during the secretory phase [37, 38]. Significantly, an elegant study by Wira’s group demonstrated that T cells isolated from tissues during proliferative phase of menstrual cycle demonstrate cytolytic capacity but those during the secretory phase do not . Therefore, the presence of IFN gamma and elevated levels of IDO expression during secretory phase, which can downmodulate perforin expression in CD8 T cells, coincides with the dampening of cytolytic T cell activity.
The second series of studies that support our hypothesis is based on the analyses of IDO expression during pregnancy. Elevated IDO expression has been found in the epithelium of cervical glands, Fallopian tubes and endometrial stromal cells during decidualization in both animal and human studies [37, 38, 40, 41]. Interestingly, CD8 T cells comprise the largest fraction of T cells at the fetal-maternal interface . However, analysis of perforin expression of CD8 T cells during pregnancy revealed that while peripheral CD8 T cells express perforin, this cytolytic molecule is deficient in decidual CD8 T cells [43, 44]. These finding is consistent with the studies by Mellor et al. suggesting that IDO-mediated T cell dysfunction plays a significant role in the induction of feto-maternal tolerance [45–48]. Therefore, it seems apparent that the IFN gamma-IDO-perforin axis is an important component of the regulation of CD8 T cell cytolytic activity in the female genital tract.
If our hypothesis that IFN gamma-mediated induction of IDO is the primary mechanism involved in lowering perforin content of CD8 TEM cells in the endocervix, studies on the CD8 T cell immune repertoire of C. trachomatis infected women stratified based on their stage of menstrual cycle at the time of sample collection would be desirable, as this would clarify whether elevation of IFN gamma levels during C. trachomatis infection could overcome the low IDO expression during the proliferative stage. This would shed light on whether regardless of the stage of the menstrual cycle, the CD8 TEM cells in the endocervix are consistently low in perforin content during C. trachomatis infection.
The findings in this study suggest that perforin-dependent CD8 T cell-mediated cytoxicity may play a limited role in immune control of human endocervical C. trachomatis infection. However, further studies are needed to clearly establish the mechanism that drives the decrease in perforin levels in normal and C. trachomatis-infected endocervix. Nevertheless, despite the challenging nature of human studies in the female genital tract, we have generated ex vivo data that provides important insights into the endocervical immunological repertoire that may influence the outcome of C. trachomatis infection at this site.
Immunohistochemical assessment of CD8 T cell infiltrates
Archived endocervical tissue paraffin blocks were utilized to assess the perforin and granzyme expression of endocervical CD8 T cell infiltrates in situ. Collection of endocervical tissues was approved by Louisiana State University Health Sciences Center Institutional Review Board. The endocervical tissues were derived from biopsies or discarded hysterectomy specimen. All specimens were screened for the presence of inclusions by chlamydial LPS staining. A confirmatory test of chlamydial positivity was performed on 3 of the 4 chlamydial-LPS positive tissues by ompA genotyping as previously described . Endocervical tissues positive for C. trachomatis infection (n=4) and endocervical tissues negative for C. trachomatis infection (n=6) were analyzed by immunohistochemical staining for CD3, CD8 and perforin expression. In each experiment, sections of cell pellet consisting of peripheral blood mononuclear cells buffered with HeLa 229 cells were used as a positive control, while staining with isotype-matched irrelevant antibodies were used as negative controls. Immunohistochemical staining was undertaken by first cutting 4 μM sections of tissue which were immediately fixed on glass slides. Paraffin wax was then removed by baking the slides at 65°C for 1 hour, after which the slides were soaked in Antigen Retrieval solution (Biocare) and heated in a de-cloaking chamber (Biocare) for 20 minutes. The processed sections of tissues on the slides were then blocked using Background Sniper blocking reagent (Biocare) to prevent non-specific background staining for 1 hour at room temperature. Individual tissue sections were then reacted with the following primary antibodies: Anti-CD3 (Dakocytomation), anti-CD8 (Biocare), anti-perforin (Biolegend) or isotype-matched control (BD Biosciences) solution and incubated for 1 hour. After several washes with phosphate buffered saline (PBS), the tissue sections were incubated with appropriate secondary-antibodies conjugated to alkaline phosphatase. The slides were then washed with PBS to remove unbound antibodies, and Vulcan Fast Red chromogen system (Biocare) was added and allowed to develop. After a substrate reaction was observed in positive controls, the slides were soaked in distilled water and counterstained with hematoxylin. Tissues were then dehydrated in a series of methanol and fixed on the slide by covering with coverslip with permanent mounting medium, VectaMount (Vector Laboratories). The differences in number of CD3 and CD8 T cell infiltrates were assessed using Student’s t-test after checking the assumptions of normality and homogeneity of variance, followed by confirmatory analyses with Wilcoxon Rank Sum test.
To assess of the cytolytic potential of CD8 T cells in the blood and endocervix, we recruited participants into a study through the Delgado Clinic, New Orleans, Louisiana. Written informed consent as approved by the Louisiana State University Health Sciences Center Institutional Review Board was obtained from each participant. A total of 21 paired blood and endocervical cell samples were collected from women 18–30 years old attending the clinic who were enrolled based on satisfying at least one of the following criteria: (1) clinical evidence of cervicitis, (2) having a male partner who was tested positive for C. trachomatis infection (CT+) and (3) a positive test result for C. trachomatis infection by nucleic acid amplification test (NAAT) 3 to 30 days prior to enrolment. The participants provided information on demographics, history of previous sexually transmitted infections, antibiotic usage, and sexual behaviour. The participants were also examined by a nurse practitioner for mucupurulent cervical and vaginal discharge, bleeding and presence of clue cells. Urine samples were obtained to test for Neisseria gonorrhoea and C. trachomatis infection by NAAT. The C. trachomatis positive population were defined by a positive C. trachomatis NAAT result and confirmed with a C. trachomatis positive culture. Additional vaginal swabs were taken to assess for Trichomonas vaginalis, yeast infection, and bacterial vaginosis as previously described . HIV positive patients were excluded from the study.
Sample collection and processing
To analyze the immune cell repertoire in the endocervix of women enrolled in the study, parallel samples of whole blood (40 mL) and endocervical cells collected using two cytobrushes were performed as previously described. Peripheral blood mononuclear cells (PBMC) were isolated by conventional ficoll differential centrifugation, and endocervical cells were isolated from the cytobrushes following the previously established protocol in our laboratory .
Immunophenotyping by multiparameter flow cytometry
To analyze the cytolytic potential of systemic and endocervical CD8 T cells, polychromatic (6-color) flow cytometry was performed. After processing the PBMC and endocervical cells, aliquots of these cells were made. One aliquot of cells was stained with fluorescently labeled antibodies against surface markers: CD56-APC (BD Pharmingen), CD3-PerCP Cy5.5 (BD Biosciences), CD4-Alexa Fluor 700 (Biolegend), CD8-APC-Cy7 (BD Pharmingen). Second aliquot for Isotype controls was stained with isotype-matched fluorescent antibodies: APC IgG1k Isotype (BD Biosciences), PerCP Cy5.5 IgGk isotype (BD Biosciences), Alexa Flour 700 IgG1k isotype (Biolegend), APC-Cy7 IgG1k Isotype (BD Biosciences). The cells were then permeabilized using Cytofix/Cytoperm (BD Pharmingen), a formulation of paraformaldehyde and saponin, to fix and permeabilize the cells. Following permeabilization, the cells were stained for intracellular proteins using labeled antibodies against Perforin-FITC (Abcam) and Granzyme B-PE (Cell Sciences). The second isotype aliquot was stained with FITC IgG2b Isotype (BD Biosciences) and PE IgG1 Isotype (BD Biosciences). CD4 T cells and NK cells were also analyzed to serve as cellular controls. Granzyme was utilized as intracellular staining control. Using the polychromatic flow cytometry approach, the different immune cells were simultaneously identified and cytolytic potentials measured. The percentage of cells positive for perforin was determined by gating the cells based on the threshold fluorescence of the FITC IgG2b Isotype control.
CD8 T cell phenotyping
To further analyze CD8 T cell subpopulations, a third aliquot of cell preparation were stained for CD3-PerCP Cy5.5 and CD8-APC Cy7 in conjunction with CCR7-APC (R&D Systems) and CD45 RA-Alexa Fluor 700 (AbD Serotec), perforin-FITC (Abcam) and granzyme B-PE (CellSciences). This is to categorize the different subpopulations of CD8 T cells following the classification by Sallusto et al.[8, 9]. Further phenotyping of CD8 T cells allowed the identification of the different CD8 T cell subpopulation for a more extensive analysis of memory CD8 T cell population.
PBL-HeLa 229 cervical epithelial cell co-culture
HeLa 229 cervical epithelial cells were obtained from the ATCC, and cultured in complete RPMI 1640 (cRPMI) culture medium with 10% human AB serum (Sigma); supplemented with 200 mM glutamine (Invitrogen) and 0.25% (wt/vol) glucose (Sigma). HeLa cells were seeded in a 12-well culture plate and cultivated for 24 to 36 hours until about 80% confluence was achieved. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood as described above. The isolated PBMCs were then placed in 6-well culture dish and incubated at 5% CO2 at 37°C for 4 hours to allow monocytes to adhere to the plastic. The non-adherent-PBLs were then collected, washed and counted using a heamocytometer. The PBLs were then placed on cell culture transwell insert on laid on top of a well on a 12 well plate without or with HeLa cells. The cells were cultured for 38 hours in the absence or presence of 600 U/mL IFN gamma in cRPMI. The cells were harvested, and the viability of the cells were assessed by trypan blue staining to confirm that ~95% of the cells are viable. The cells were then stained with monoclonal antibodies against CD3, CD8, CD45RA, CCR7, perforin and granzyme, and flow cytometric analyses were performed as described above.
Data were summarized using means (+ standard deviations), medians, and percentages as appropriate. Normality assumptions were assessed using the Shapiro-Wilks test, and where they were violated, parametric analyses were confirmed with analogous nonparametric methods. Differences between levels of CD3 and CD8 cells in C. trachomatis-positive and C. trachomatis-negative tissues were tested using Student’s t-test (Wilcoxon Rank Sum test). Paired blood and endocervical specimens were assessed usi`ng paired t-test (Wilcoxon Signed Rank test), and repeated measures ANOVA (Signed Rank and Rank Sum tests) was used to determine if blood versus endocervical differences varied with C. trachomatis infection status (interaction). SAS statistical software (version 9.2) was used for all analyses.
This work is dedicated to Ms. Barbara Smith, RNP, who, until her untimely passing, worked tirelessly not only in collecting samples but in caring for patients attending the Delgado Clinic. The study was funded by NIH grant U19AI061972 and the LSUHSC Research Enhancement Fund. Flow cytometric experiments were performed at the LSUHSC Flow Cytometry Shared Resource that is supported in part as a shared facility of the LSUHSC School of Medicine, the Comprehensive Alcohol Research Center (NIAAA P60AA009803) and by the Louisiana Vaccine Center (Louisiana Board of Regents).
- Smyth MJ, Trapani JA: Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today. 1995, 16 (4): 202-206.PubMedView ArticleGoogle Scholar
- Trapani JA, Jans DA, Jans PJ, Smyth MJ, Browne KA, Sutton VR: Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent. J Biol Chem. 1998, 273 (43): 27934-27938.PubMedView ArticleGoogle Scholar
- Uellner R, Zvelebil MJ, Hopkins J, Jones J, MacDougall LK, Morgan BP, Podack E, Waterfield MD, Griffiths GM: Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain. EMBO J. 1997, 16 (24): 7287-7296.PubMedPubMed CentralView ArticleGoogle Scholar
- Tschopp J, Schafer S, Masson D, Peitsch MC, Heusser C: Phosphorylcholine acts as a Ca2+−dependent receptor molecule for lymphocyte perforin. Nature. 1989, 337 (6204): 272-274.PubMedView ArticleGoogle Scholar
- Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994, 369 (6475): 31-37.PubMedView ArticleGoogle Scholar
- Lanzavecchia A, Sallusto F: Understanding the generation and function of memory T cell subsets. Curr Opin Immunol. 2005, 17 (3): 326-332.PubMedView ArticleGoogle Scholar
- Germain RN: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994, 76 (2): 287-299.PubMedView ArticleGoogle Scholar
- Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999, 401 (6754): 708-712.PubMedView ArticleGoogle Scholar
- Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004, 22: 745-763.PubMedView ArticleGoogle Scholar
- Champagne P, Dumont AR, Sekaly RP: Learning to remember: generation and maintenance of T-cell memory. DNA Cell Biol. 2001, 20 (12): 745-760.PubMedView ArticleGoogle Scholar
- Sutton VR, Waterhouse NJ, Baran K, Browne K, Voskoboinik I, Trapani JA: Measuring cell death mediated by cytotoxic lymphocytes or their granule effector molecules. Methods. 2008, 44 (3): 241-249.PubMedView ArticleGoogle Scholar
- Masopust D, Vezys V, Wherry EJ, Barber DL, Ahmed R: Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J Immunol. 2006, 176 (4): 2079-2083.PubMedView ArticleGoogle Scholar
- Shacklett BL, Cox CA, Quigley MF, Kreis C, Stollman NH, Jacobson MA, Andersson J, Sandberg JK, Nixon DF: Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection. J Immunol. 2004, 173 (1): 641-648.PubMedView ArticleGoogle Scholar
- Rukavina D, Laskarin G, Rubesa G, Strbo N, Bedenicki I, Manestar D, Glavas M, Christmas SE, Podack ER: Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood. 1998, 92 (7): 2410-2420.PubMedGoogle Scholar
- Arnold V, Balkow S, Staats R, Matthys H, Luttmann W, Virchow JC: Increase in perforin-positive peripheral blood lymphocytes in extrinsic and intrinsic asthma. Am J Respir Crit Care Med. 2000, 161 (1): 182-186.PubMedView ArticleGoogle Scholar
- Kumar S, Li Q, Dua A, Ying YK, Bagchi MK, Bagchi IC: Messenger ribonucleic acid encoding interferon-inducible guanylate binding protein 1 is induced in human endometrium within the putative window of implantation. J Clin Endocrinol Metab. 2001, 86 (6): 2420-2427.PubMedGoogle Scholar
- Vives A, Balasch J, Yague J, Quinto L, Ordi J, Vanrell JA: Type-1 and type-2 cytokines in human decidual tissue and trophoblasts from normal and abnormal pregnancies detected by reverse transcriptase polymerase chain reaction (RT-PCR). Am J Reprod Immunol. 1999, 42 (6): 361-368.PubMedView ArticleGoogle Scholar
- Roan NR, Starnbach MN: Antigen-specific CD8+ T cells respond to Chlamydia trachomatis in the genital mucosa. J Immunol. 2006, 177: 7974-7979.PubMedView ArticleGoogle Scholar
- Arno JN, Ricker VA, Batteiger BE, Katz BP, Caine VA, Jones RB: Interferon-gamma in endocervical secretions of women infected with Chlamydia trachomatis. J Infect Dis. 1990, 162: 1385-1389.PubMedView ArticleGoogle Scholar
- Feng GS, Taylor MW: Interferon gamma-resistant mutants are defective in the induction of indoleamine 2,3-dioxygenase. Proc Natl Acad Sci USA. 1989, 86: 7144-7148.PubMedPubMed CentralView ArticleGoogle Scholar
- Liu H, Liu L, Bizargity P, Hancock WW, Visner GA: Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression. J Immunol. 2009, 183: 1022-1031.PubMedView ArticleGoogle Scholar
- Olive AJ, Gondek DC, Starnbach MN: CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa. Mucosal Immunol. 4 (2): 208-216.Google Scholar
- Rank RG, Bowlin AK, Kelly KA: Characterization of lymphocyte response in the female genital tract during ascending Chlamydial genital infection in the guinea pig model. Infect Immun. 2000, 68 (9): 5293-5298.PubMedPubMed CentralView ArticleGoogle Scholar
- Morrison SG, Morrison RP: In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infect Immun. 2000, 68 (5): 2870-2879.PubMedPubMed CentralView ArticleGoogle Scholar
- Starnbach MN, Bevan MJ, Lampe MF: Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars. Infect Immun. 1995, 63 (9): 3527-3530.PubMedPubMed CentralGoogle Scholar
- Starnbach MN, Bevan MJ, Lampe MF: Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol. 1994, 153 (11): 5183-5189.PubMedGoogle Scholar
- Kelly KA, Wiley D, Wiesmeier E, Briskin M, Butch A, Darville T: The combination of the gastrointestinal integrin (alpha4beta7) and selectin ligand enhances T-Cell migration to the reproductive tract during infection with Chlamydia trachomatis. Am J Reprod Immunol. 2009, 61 (6): 446-452.PubMedPubMed CentralView ArticleGoogle Scholar
- Kelly KA, Rank RG: Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun. 1997, 65 (12): 5198-5208.PubMedPubMed CentralGoogle Scholar
- Hawkins RA, Rank RG, Kelly KA: Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo. Infect Immun. 2000, 68 (10): 5587-5594.PubMedPubMed CentralView ArticleGoogle Scholar
- Ficarra M, Ibana JS, Poretta C, Ma L, Myers L, Taylor SN, Greene S, Smith B, Hagensee M, Martin DH: A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am J Reprod Immunol. 2008, 60 (5): 415-425.PubMedPubMed CentralView ArticleGoogle Scholar
- Lampe MF, Wilson CB, Bevan MJ, Starnbach MN: Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun. 1998, 66 (11): 5457-5461.PubMedPubMed CentralGoogle Scholar
- Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL: Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th-1-like cytokine response associated with fibrosis and scarring. Infect Immun. 1997, 65: 2175-2182.PubMedPubMed CentralGoogle Scholar
- Murthy AK, Li W, Chaganty BK, Kamalakaran S, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, Arulanandam BP: Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect Immun. 79 (7): 2928-2935.Google Scholar
- Perry LL, Feilzer K, Hughes S, Caldwell HD: Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. Infect Immun. 1999, 67 (3): 1379-1385.PubMedPubMed CentralGoogle Scholar
- Ibana JA, Aiyar A, Quayle AJ, Schust DJ: Modulation of MICA on the surface of Chlamydia trachomatis-infected endocervical epithelial cells promotes NK cell-mediated killing. FEMS Immunol Med Microbiol. 65 (1): 32-42.Google Scholar
- Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA: Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003, 281 (1–2): 65-78.PubMedView ArticleGoogle Scholar
- Sedlmayr P, Blaschitz A, Wintersteiger R, Semlitsch M, Hammer A, MacKenzie CR, Walcher W, Reich O, Takikawa O, Dohr G: Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta. Mol Hum Reprod. 2002, 8 (4): 385-391.PubMedView ArticleGoogle Scholar
- Kudo Y, Hara T, Katsuki T, Toyofuku A, Katsura Y, Takikawa O, Fujii T, Ohama K: Mechanisms regulating the expression of indoleamine 2,3-dioxygenase during decidualization of human endometrium. Hum Reprod. 2004, 19 (5): 1222-1230.PubMedView ArticleGoogle Scholar
- White HD, Crassi KM, Givan AL, Stern JE, Gonzalez JL, Memoli VA, Green WR, Wira CR: CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol. 1997, 158 (6): 3017-3027.PubMedGoogle Scholar
- Drenzek JG, Breburda EE, Burleigh DW, Bondarenko GI, Grendell RL, Golos TG: Expression of indoleamine 2,3-dioxygenase in the rhesus monkey and common marmoset. J Reprod Immunol. 2008, 78 (2): 125-133.PubMedView ArticleGoogle Scholar
- von Rango U, Krusche CA, Beier HM, Classen-Linke I: Indoleamine-dioxygenase is expressed in human decidua at the time maternal tolerance is established. J Reprod Immunol. 2007, 74 (1–2): 34-45.PubMedView ArticleGoogle Scholar
- Tilburgs T, van der Mast BJ, Nagtzaam NM, Roelen DL, Scherjon SA, Claas FH: Expression of NK cell receptors on decidual T cells in human pregnancy. J Reprod Immunol. 2009, 80 (1–2): 22-32.PubMedView ArticleGoogle Scholar
- Tilburgs T, Scherjon SA, Roelen DL, Claas FH: Decidual CD8+CD28- T cells express CD103 but not perforin. Hum Immunol. 2009, 70 (2): 96-100.PubMedView ArticleGoogle Scholar
- Tilburgs T, Schonkeren D, Eikmans M, Nagtzaam NM, Datema G, Swings GM, Prins F, van Lith JM, van der Mast BJ, Roelen DL: Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J Immunol. 185 (7): 4470-4477.Google Scholar
- Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998, 281 (5380): 1191-1193.PubMedView ArticleGoogle Scholar
- Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH: Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol. 2001, 2 (1): 64-68.PubMedView ArticleGoogle Scholar
- Mellor AL, Munn DH: Extinguishing maternal immune responses during pregnancy: implications for immunosuppression. Semin Immunol. 2001, 13 (4): 213-218.PubMedView ArticleGoogle Scholar
- Mellor AL, Munn DH: Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J Reprod Immunol. 2001, 52 (1–2): 5-13.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.